Experimental evidence strongly implicates hyperglycaemia in the pathogenesis of diabetic retinopathy.
Retina and cerebral cortex are embryologically similar, yet have been found by us [5] and others [6, 7] to differ in their susceptibility to develop microvascular lesions in diabetes. The frequency of acellular capillaries, microaneurysms and pericyte loss becomes statistically significantly greater than normal in retinal capillaries of diabetic or galactosaemic animals. Cerebral capillaries, in contrast, fail to develop these lesions, even in the same animals that have developed statistically significant retinovascular disease [5] . Inasmuch as both retinal and cerebral vascular beds are exposed to similar concentrations of blood hexose, these observations suggest that systemic blood glucose concentration is not the only factor influencing the development of retinal vascular disease in diabetes.
Most of the biochemical mechanisms that have been postulated to contribute in the pathogenesis of diabetic retinopathy (including increased activities of aldose reductase or protein kinase C (PKC), and aspects of non-enzymatic glycation or oxidative stress) depend on excessive transport or accumulation of glucose within the retina or its microvasculature. Transport of hexose into cells can vary between cell types and such differences might be important in determining which cells are adversely effected by hyperglycaemia. The initial step in delivery of glucose to the retina or brain is its transport across the microvascular endothelium by the GLUT-1 glucose transporter [8] .
Tissue glucose has been measured previously in the retina [9, 10] or brain [11±13] of diabetic animals but glucose concentrations of the two embryologically similar tissues have not been directly compared. In our study, effects of diabetes on intracellular concentrations of glucose in retina and cerebral cortex are compared. The effect of diabetes on expression of GLUT-1, the major glucose transporter in the vasculature of the retina and brain, on the luminal surface of the vascular beds also is compared between the two tissues.
Materials and methods
Male Sprague-Dawley rats weighing 225±250 g were assigned at random to become diabetic or to remain as non-diabetic controls. Diabetes was induced by the injection of freshly prepared solution of streptozotocin in citrate buffer (pH 4.5) at 55 mg/kg of body weight in the tail vein. We measured 24-h urine volume (over 2±3 consecutive days) beginning about 1 week after the streptozotocin injection to confirm the development of diabetes and again after 6 to 8 weeks of diabetes. Body weight and average daily food consumption were measured weekly. Treatment of animals conformed to the American National Institutes of Health ªPrincipals of laboratory animal careº, Association for Research in Vision and Ophthalmology (ARVO) Resolution on Treatment of Animals in Research, as well as to specific institutional guidelines.
Tissue concentrations of glucose were estimated by two methods. The first was a direct measure of tissue glucose concentrations using enzyme cycling (quantitative histochemistry) micromethods. Intracellular concentrations of hexose were estimated also using an indirect method based on the extent of Amadori product formation on intracellular proteins. Nonenzymatic glycation and formation of Amadori products are greatly stimulated by increased sugar concentrations in diabetes [14, 15] .
Direct assay of tissue glucose. Retinas and cerebral cortex of anaesthetized normal (n = 10) or diabetic (2 month; n = 10) rats were frozen in situ by the funnel freezing method [16] . This method freezes tissues with liquid nitrogen while blood continues to be oxygenated and circulate through the tissues. Funnel freezing has been found to be a good method to collect neural tissues for assay of glucose and other metabolites without artefactual loss [16, 17] . Animals were maintained on a respirator throughout the freezing process and blood gases and pH remained normal. After the head was frozen, cryosections of eye and cerebral cortex grey matter were cut (20 mm) and lyophilized. Microsamples of neural retina (including all layers; collected from posterior retina) and cerebral cortex grey matter were dissected from the lyophilized tissue under a stereozoom microscope with transillumination. Samples were weighed with a quartz fishpole balance (average dry weight = 1.5 mg) and tissue glucose assayed using the enzyme cycling techniques (quantitative histochemistry) described originally by Lowry and Passonneau and later used by Lust and others [17] . The first step involves incubation of the tissue sample with hexokinase, glucose-6-phosphate dehydrogenase, NADP and excess concentrations of ATP to stoichiometrically generate NADPH from glucose. The reaction is terminated in 0.2 N NaOH at 80 C which also destroys all the excess NADP. The NADPH is amplified by enzymic cycling and one of the cycling products is determined fluorometrically with the appropriate enzyme reaction. The lower level of sensitivity of the assay is less than 0.1 pmol. Metabolite concentrations are reported as nmol per mg dry tissue weight.
Non-enzymatic glycation of intracellular protein. Amadori products (due to non-enzymation glycation) on intracellular protein were measured as an indirect estimate of intracellular glucose concentration, because glucose is a major glycating agent in cells (especially in diabetes). Tissues from normal and diabetic (2 month) animals (both n = 8) were sonicated in buffer (10 mmol/l TRIS containing 0.5 mmol/l EGTA and 0.25 mol/l sucrose; pH 7.4) and centrifuged at high speed (120 000 g for 60 min) to remove proteins other than those in the cytoplasmic fraction. The supernatant containing these cytoplasmic proteins was applied to commercially available affinity columns containing m-phenylboronic acid (Glyco-Gel; Pierce, Rockford, Ill., USA), which retain proteins that have been non-enzymatically glycated. Chromatography was done according to the manufacturer's instructions. Protein content of the bound and unbound fractions was measured [18] and the per cent of cytoplasmic protein that was glycated was calculated.
Measurement of GLUT-1. The expression of GLUT-1 was measured in homogenates of retina and in isolated luminal membranes of the retinal and cerebral vasculatures of seven non-diabetic rats and seven rats that had been diabetic for 2 months. Tissues were homogenized in 10 mmol/l TRIS containing 0.5 mmol/l EGTA and 0.25 mol/l sucrose (pH 7.4). Protein (10 mg of retinal homogenate and 2 mg luminal membrane stripped from vascular endothelium) were loaded per lane and electrophoresed as described previously [19] . Protein was measured using BCA reagent (Pierce). Primary antibody (anti-GLUT-1; 1/1000 dilution) was obtained from Charles River Pharmaservices (Southbridge, Mass., USA). After SDS-PAGE and transfer to nitrocellulose membrane, blots were incubated in 5 % non-fat milk and then incubated for 1 h with primary antibody and peroxidase-labelled goat anti-rabbit IgG. Blots were developed using an enhanced chemiluminescence kit (Amersham Life Science; Amersham, England). Films were digitized and the intensity of bands was quantitated using OS-Scan Image Analysis software (USB State Biochemical, Cleveland, Ohio, USA). To show comparable loading of lanes, some membranes were cut in two, with the portion corresponding to molecular weight greater than about 70 000 M r stained with antibody against the intrinsic membrane protein, Na,K ATPase (a1 subunit; University of Iowa Hybridoma facility, USA) and the portion corresponding to lower molecular weights stained with anti-GLUT-1.
Isolation of the luminal surface of the retinal and cerebral vasculatures. The luminal plasmalemma of the endothelium as well as attached plasmalemma vesicles was isolated from 18 normal rats and 16 diabetic rats by perfusing in situ with buffer to remove blood, followed by a cationized silica to bind to the luminal surface of the vascular endothelium and then anionic polyacrylate [20±22] . The result is a particulate coat on the endothelium that strongly adheres to the luminal plasmalemma, resists tissue homogenization, thereby allowing purification of the luminal plasmalemma. Methods have been detailed elsewhere [20, 23] but are summarized here. A cannula was placed in the ascending aorta of anaesthetized rats such that perfusate entered both carotids. Animals were injected with nitroprusside (vasodilator) and heparin and then the head perfused sequentially with DMEM/nitroprusside (to remove blood), (morpholino)ethanesulphonic acid (MES)-buffered saline, colloidal silica, MES-buffered saline, 1.5 % sodium polyacrylate in MES-buffered saline and HEPES-buffered sucrose (pH 7.2) containing protease inhibitors (o-phenanthroline, phenylmethylsulphonyl fluoride, leupeptin, pepstatin A and trans-epoxysuccinyl-l-leucyamido(4-guanidino)butane). After perfusion, both retinas or cerebral cortex grey matter were homogenized in the aforementioned solution containing freshly prepared protease inhibitors and the homogenate centrifuged (20 min at 60 000 g) in a Nycodenz discontinuous density gradient (1.02 g/ml and 0.7 g/ml of Nycodenz in 25 mmol/l HEPES containing 60 mmol/l sucrose) to yield a homogeneous pellet of luminal plasmalemma fragments adherent to silica particles. The membrane fragments were dissolved off the insoluble beads with 50 mmol/l HEPES buffer (pH 7.4) containing 150 mmol/l NaCl, 5 mmol/l each of EDTA and EGTA, 20 mmol/l sodium pyrophosphate, 1 mmol/l orthovanadate, 20 mmol/l sodium fluoride and 1 % Nonide P-40 (detergent). Samples were prepared for western blots by solubilizing in SDS sample buffer. The total amount of protein isolated in the endothelial luminal plasmalemma from both retinas per animal was about 50±60 mg.
Statistical analysis. The data are summarized with the means SD. The normal and diabetic groups were compared with the parametric t-test. The nom-parametric Mann-Whitney U test yielded similar conclusions. Groups were regarded as significantly different at a p value less than 0.05.
Results
Diabetic animals were insulin-deficient, as evidenced by increased concentrations of non-fasting blood glucose (non-diabetic, 8.1 mmol/l 0.6; diabetic, 19.2 2.9) and 24-h urine volume (non-diabetic, 8 mls/ day 2; diabetic, 132 27). Body weight (490 116 g and 272 58 g) was significantly less in diabetic than in normal animals.
Direct measure of tissue glucose by quantitative histochemistry indicates that free glucose concentration in the retina of diabetic animals was increased fourfold above that seen in non-diabetic animals ( Fig. 1 ; p < 0.001). In contrast, glucose content of the cerebral cortex from the same diabetic animals was not significantly increased (p = 0.5). Retinas and brains were collected from the same animals, so both tissues were exposed to the same blood glucose concentrations. Expressing glucose concentration in retina and cerebrum relative to that in blood from the same animals indicates that cerebral glucose concentration increased in proportion to the rise in blood glucose. In both non-diabetic animals and diabetic animals, the ratio of glucose in cerebrum to that in blood, nmol glucose in cerebrum=mg cerebral protein nmol glucose in blood=ml blood remained constant at 1.9. In contrast, diabetes increased the glucose concentration in retina almost twofold greater than the increase in blood glucose concentration (ratio of glucose in retina to glucose in blood = 3.4 and 6.2 for non-diabetic and diabetic, respectively). Even in non-diabetic animals, the free glucose concentration in the retina was greater than in cerebral grey matter.
Non-enzymatically glycated proteins (Amadori products) in cytoplasm of the retina and cerebral cortex grey matter of non-diabetic and diabetic rats also were quantified as an independent estimate of intra- The luminal cell membrane of the retinal and cerebral vasculatures (the sites at which glucose is transferred from blood into tissue) had different amounts of GLUT-1 in non-diabetic animals, the luminal surface of retinal endothelial cells possessing considerably more GLUT-1 than did the cerebral vasculature (Fig. 3) . Diabetes decreased expression of the glucose transporter on the luminal surface of the retinal vasculature to a value only 45 % of that observed in normal animals (p < 0.0001; Fig. 4) . Consistent with this, diabetes caused a decrease in GLUT-1 expression also in homogenates of whole retina (36 % decrease compared with normal; p < 0.013; not shown). Expression of the glucose transporter in the luminal surface of the cerebral vasculature was not decreased in diabetes; the cerebral vasculature of diabetic animals tended to have more GLUT-1 protein (22 % more) than found in the luminal plasmalemma of cerebral vessels from non-diabetic animals (not significant; p = 0.11; Fig. 5 ).
Discussion
Data from two different methods suggest that diabetes increases intracellular concentrations of glucose significantly more in the retina than in cerebral cortex. The two different methods used to estimate tissue glucose complement each other. For example, measurement of Amadori products of intracellular proteins yields a variable that has the advantages of being less labile than free glucose, and focuses primarily on the intracellular environment. Amadori products, however, might not occur solely from glucose, and measurement of tissue glucose clearly addresses this issue.
Increased concentrations of intracellular glucose in the retina of diabetic animals is not surprising, having been suggested by PKC activation, oxidative stress and polyol formation in retinas of diabetic animals [24±30]. The brain however, responds different- The different biochemical responses of these two tissues to hyperglycaemia might be due to different amounts of PKC, aldose reductase or enzymes in the production or metabolism of reactive oxygen species but data we present suggests that differences in intracellular accumulation of glucose also might be important. Diabetes has been reported to cause some increase in intracellular glucose concentration in cerebral cortex [11±13] but non-invasive measurement of glucose in the intact brain of humans using 13 C NMR spectroscopy indicates that the tissue is relatively protected from hyperglycaemia, brain glucose concentrations being only 3 mmol/l when plasma glucose is more than 12 mmol/l [34] .
The cause of this diabetes-induced tissue difference in glucose accumulation is not clear. Glucose concentration within cells reflects a balance between movement of the sugar into and out of cells and the intracellular rate of glucose metabolism. Whether or not diabetes has different effects on the rate of glucose metabolism in the retina and cerebrum of diabetic animals is not clear. There is, however, more GLUT-1 (in capillaries and retinal pigment epithelium) delivering glucose to neural retina than there is for cerebral cortex grey matter [35] , raising a possibility that relatively more glucose is delivered to retina than to cerebral cortex grey matter. Reportedly GLUT-1 accounts for all glucose transport from blood into the brain (and presumably retina) [8] . In our hands, GLUT-1 expression in retinal homogenates and in intact isolated retinal microvessels of diabetic rats was subnormal [35] , not increased as might have been inferred from the observed increase in tissue glucose concentration in the retina of diabetic animals. Consistent with this, GLUT-1 now is shown by us to be decreased also on the luminal surface of the retinal vasculature, the surface at which glucose is moved into the endothelium from blood. The luminal surface of cerebral capillaries from the same animals showed no such reduction in GLUT-1 expression in diabetes. The different response of GLUT-1 in the cerebrum and retina to the same increase in blood glucose remains to be explained. In another study, normal or increased numbers of GLUT-1 transporters in capillaries of three diabetic patients were observed, and thus the opposite conclusion about the effect of diabetes on GLUT-1 density in retinal capillaries was reached [36] . The reason for the different conclusions is not clear but that study differed from ours in subjects (humans vs rats), the duration of diabetes (years vs 2 months) and the methods used to detect GLUT-1 (ultrastructural immunohistochemisty vs immunochemical analysis of tissue homogenates and isolated vessels).
Glucose enters the retina from blood also across the retinal pigment epithelium (RPE) and appreciable GLUT-1 has been observed in those cells [35, 37±39] . In contrast to the diabetes-induced decrease in expression of GLUT-1 in retinal capillaries, we previously found that diabetes causes no reduction in GLUT-1 expression in RPE cells [35] . This data suggests that the increase observed in retinal glucose in diabetes might be due in part to transport across the RPE.
Vascular permeability has been found to be increased in the retina in diabetes, whereas the brain shows little or no permeability defect [40±43], offering a potential mechanism for glucose entry into neural retina that is independent of glucose transporters. The difference in vulnerability of the barriers in the two tissues has been suggested to be due to differences in the tissue surrounding the vessels [43] . The dia- A B betes-induced increase in retinal permeability reportedly can be normalized using pharmacological agents, including aldose reductase inhibitors [44, 45] . This observation suggests that the retinal glucose concentration is increased before the permeability defect develops, because the kinetics of aldose reductase indicates that increased activity of the enzyme is a result of increased intracellular hexose concentrations. Increased retinal permeability clearly can exacerbate glucose accumulation in diabetes, but the extent to which it initiates glucose accumulation in the retina is not clear.
Although the recognized histopathology of diabetic retinopathy involves the microvasculature, it seems unlikely that the diabetes-induced increase in glucose concentration observed by us in the retina is restricted only to vascular cells. The vasculature is only a minor fraction of tissue, so the doubling of glucose in the retina of diabetic animals suggests that glucose is increased also in non-vascular cells. Others have postulated a role of glia or neuronal abnormalities in the pathogenesis of diabetic retinopathy [46] .
Histological studies have shown that the microvasculature of the cerebral cortex is relatively protected from the diabetes-induced microvascular disease that develops in retinal microvessels [5±7]. It seems likely that the relative protection of the cerebral microvasculature from diabetes-induced microvascular disease is due in part to lesser accumulation of glucose in cerebral cortex than in the retina. Identification of how retinal glucose concentration becomes disproportionately increased in diabetes and how glucose accumulation is minimized in cerebral cortex, might offer a new perspective on ways to inhibit the development of diabetic retinopathy.
